Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This study will recruit 480 acute stroke patients with symptomatic intracranial stenosis (M1
segment of Middle cerebral artery (MCA) or basilar artery).
They will be randomly assigned into cilostazol group or clopidogrel group. Every patients
will take 100mg of aspirin a day additionally.
The primary outcome variable of this study is Progression rate of symptomatic intracranial
stenosis on magnetic resonance angiogram (MRA).